Search Header Logo

GLP-1s: Approval and Clinical Concerns

Authored by Megan Kim

Science

University

Used 3+ times

GLP-1s: Approval and Clinical Concerns
AI

AI Actions

Add similar questions

Adjust reading levels

Convert to real-world scenario

Translate activity

More...

    Content View

    Student View

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

10 sec • 1 pt

GLP-1s work by _____ satiety and insulin secretion and _____ GI motility

decreasing, decreasing

increasing, increasing

increasing, decreasing

decreasing, increasing

2.

MULTIPLE SELECT QUESTION

10 sec • 1 pt

GLP-1s are currently approved for

Type 1 diabetes

Weight loss

Cardiovascular protection

Obstructive sleep apnea

3.

MULTIPLE CHOICE QUESTION

10 sec • 1 pt

Which of the following GLP-1s recently got approved for obstructive sleep apnea?

Semaglutide

Dulaglutide

Liraglutide

Tirzepatide

4.

MULTIPLE CHOICE QUESTION

20 sec • 1 pt

A clinical concern of GLP-1s is that GLP-1s can cause loss of _____ and if stopped, can result in gain of _____

fat, fat

fat, muscle

muscle, fat

bone, fat

5.

MULTIPLE CHOICE QUESTION

10 sec • 1 pt

The obesity rate in adolescents has ______ in the last 30 years.

Stayed the same

Tripled

Quadrupled

Quintupled

6.

MULTIPLE CHOICE QUESTION

10 sec • 1 pt

True or false: GLP-1s have led the focus of healthcare to shift from management to prevention

False

True

7.

FILL IN THE BLANK QUESTION

20 sec • 1 pt

What is the brand name of the GLP-1 that was first approved for weight loss?

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?